PROJECT44
12.2.2020 09:02:16 CET | Business Wire | Press release
project44, the global leader in advanced visibility for shippers and logistics service providers, has experienced significant growth across Europe following several recent announcements, including opening an office in Paris , adding several new team members , and building partnerships with global technology leaders .
Since acquiring Europe’s leading visibility provider, GateHouse Logistics, in 2018, project44 has increased global growth reaching more than 300 enterprise customers with over 20% in Europe, including leading brands such as Amazon, Coop, and Yazaki.
“With an increased need for real-time data and visibility across the entire supply chain, shippers and logistics service providers need a single global provider,” said Michael Gross, Director IT, Supply Chain and Logistics at Yazaki. “We’re excited for project44’s network to grow in Europe and beyond. Their plans for expansion are critical for supporting our global supply chain.”
With coverage in about 50 countries, integrations with over 760 telematics providers, and partnerships with global technology leaders such as SAP, project44 enables customers to tap into the most extensive visibility network across North America and Europe. With European carrier onboarding available in 16 languages and applications in 14 languages, p44’s comprehensive support ensures customers see the ROI of visibility in the fastest way possible.
To accelerate this European growth, project44 opened a Paris office in December of 2019 and has since retained several key hires for continued European expansion, reaching over 80 European-based employees in Aalborg, Amsterdam, Frankfurt, and Milan.
New team members include Regional VP of Sales Mickael Devena , Value Engineering Director Jatin Garg , Head of European Marketing Lorenzo Stranges, and Strategic Account Director Marco Tarpi . Devena and Garg bring extensive experience in transportation visibility from their time at Shippeo, while Stranges and Tarpi come from global SaaS leaders, including DocuSign and IBM respectively.
Michel Stekelenburg will also join the team as the Strategic Account Director for the Benelux region. In addition to several roles in supply chain technology, Stekelenburg serves as the President of the Benelux Roundtable for the Council of Supply Chain Management Professionals (CSCMP).
To lead this growing team, project44 has promoted Executive Vice President of Operations, Jørgen B Nielsen, to General Manager of Europe. With more than 20 years of experience with technical challenges and project execution in IT and telecom, Jørgen led GateHouse Logistics through rapid growth as Chief Operating Officer.
“Building on the GateHouse Logistics’s decade of significant success and expertise, project44 has continued to expand the European visibility market, delivering a seamless product and experience for our global customers,” said Jørgen. “As supply chains increase logistics and transportation operations across geographies, project44 will continue to expand globally and provide the coverage our customers need to effectively run their businesses.”
With over $110 million USD in capital, project44 will continue to explore additional international growth to deliver a seamless transportation visibility offering for global supply chains. By partnering with leading global carriers, project44 has already started gaining coverage beyond North America and Europe in Turkey, Russia, Ukraine, and Belarus. The visibility provider will also begin extending tracking connections in Morocco.
About project44
project44 is the world’s leading advanced visibility platform for shippers and logistics service providers. project44 connects, automates and provides visibility into key transportation processes to accelerate insights and shorten the time it takes to turn those insights into actions. Leveraging the power of the project44 cloud-based platform, organizations are able to increase operational efficiencies, reduce costs, improve shipping performance, and deliver an exceptional Amazon-like experience to their customers. Connected to thousands of carriers worldwide and having comprehensive coverage for all ELD and telematics devices on the market, project44 supports all transportation modes and shipping types, including Parcel, Final-Mile, Less-than-Truckload, Volume Less-than-Truckload, Truckload, Rail, Intermodal, and Ocean. To learn more, visit www.project44.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20200212005086/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom